Regulatory Affairs & Submission Support for Obesity Drugs

As the global obesity epidemic reaches critical levels, the race to develop potent incretin mimetics (GLP-1/GIP) and novel non-peptide small molecules has intensified. Protheragen provides a specialized, end-to-end regulatory affairs & submission support service designed specifically for the high-stakes weight management market. In an industry defined by the acceleration phase, we bridge the gap between breakthrough clinical science and stringent health authority mandates. Our expertise ensures that complex data, ranging from multi-indication cardiovascular outcomes to metabolic health biomarkers, is synthesized into a high-quality technical dossier. By integrating predictive quality assurance with deep strategic intelligence, Protheragen helps sponsors navigate the specific regulatory nuances of the FDA, EMA, and emerging global markets.

Navigating Complexity, Securing Approvals: Your Trusted Gateway to Global Metabolic Markets

Protheragen offers a suite of Clinical Regulatory Services, specifically tailored to handle the complexities of anti-obesity therapy development. Our service scope integrates advanced regulatory intelligence with deep technical consulting, organized into four pillars of excellence:

Dossier Preparation & Submission Service

We manage the entire documentation lifecycle to ensure your metabolic therapies meet the highest global standards for submission.

• Global IND/NDA/BLA Filings: Strategic preparation and electronic submission of dossiers for FDA, EMA, NMPA, and PMDA.
• Technical Medical Writing: Specialized authoring of clinical study reports (CSR), Investigator's Brochures (IB), and CTD modules with a focus on weight loss efficacy and metabolic safety narratives.
• Global Bridging Strategy: Expert justification for extrapolating clinical data across different ethnic populations to support international market entry.
• Labeling & Claims Support: Technical evidence assembly for secondary endpoint claims, including cardiovascular risk reduction and glycemic control.

Compliance, CMC & Toxicology Consulting Service

Our consultants address the unique chemical and biological challenges inherent in the production of complex peptides and oral weight-loss agents.

• CMC Regulatory Strategy: Guidance on chemistry, manufacturing, and controls to ensure process validation and stability data meet evolving new standards.
• Toxicology Risk Assessment: Specialized evaluation of impurities, including nitrosamine and genotoxicity risk assessments, to prevent regulatory holds.
• Gap Analysis & Remediation: Proactive detection of technical document deficiencies, complemented by the formulation of robust action plans, to guarantee full submission readiness for every project.
• Non-clinical Safety Consulting: Strategic advice on preclinical safety data requirements for novel metabolic mechanisms.

Regulatory Lifecycle & Inspection Support Service

We ensure your product maintains compliance throughout its lifecycle while preparing your team for the rigors of health authority scrutiny.

• Inspection Readiness Programs: Mock audits and SME training to prepare clinical sites and sponsors for FDA/EMA pre-approval inspections (PAI).
• Lifecycle Management: Coordination of post-approval changes, variations, and annual reporting to maintain market authorization.
• Health Authority Liaison: Leading formal communications and consultations, such as pre-IND and end-of-Phase 2 meetings, to align with agency expectations.
• GVP System Implementation: Establishing pharmacovigilance frameworks to monitor long-term safety signals in obesity populations.

Comprehensive Quality Audit & Compliance Service

Protheragen provides independent oversight to safeguard the integrity of your clinical data and supply chain.

• Third-Party Vendor Audits: Rigorous auditing of CROs, central laboratories, and clinical sample logistics providers.
• Clinical Site (GCP) Auditing: On-site and remote audits of investigator sites to verify data authenticity and subject safety.
• QMS Development: Assistance in building or optimizing quality management systems aligned with ICH-GCP and international standards.
• CAPA Management: Guidance on implementing effective corrective and preventive actions following audit findings to ensure continuous improvement.

Contact Our Regulatory Team Today to Design a Robust Submission Roadmap.

Workflow

Our service process follows a multi-dimensional and meticulously planned trajectory, designed to proactively mitigate regulatory risks and maximize the scientific integrity of every submission:

• Strategic Gap Assessment: We conduct an initial deep dive into existing clinical and CMC data to identify regulatory blind spots. This phase includes an audit of current evidence against the latest FDA/EMA guidelines to define the most efficient and low-risk filing pathway.
• Dossier Development & Refinement: A cohesive CTD structure is meticulously constructed from multifaceted clinical, non-clinical, and CMC datasets under the guidance of our subject matter experts to facilitate a more efficient review. We focus on harmonizing the scientific narrative across all modules, ensuring that efficacy claims are backed by robust data and that technical summaries are transparent and defensible.
• Internal Peer Review & Quality Check: A rigorous multi-layer review is performed on every component of the submission to guarantee absolute technical accuracy and internal consistency. This includes a cross-functional validation of statistics, medical writing, and regulatory compliance to preemptively address potential queries from agency reviewers.
• Mock Inspection & Readiness Training: High-stakes regulatory audits are simulated at both the sponsor and investigative site levels to evaluate and strengthen organizational readiness. This intensive preparation ensures that all stakeholders, including lead scientists and site coordinators, are fully equipped to handle official inquiries with confidence, clarity, and documented evidence.
• Submission & Lifecycle Response: Following the formal filing, we remain deeply engaged in managing all agency information requests (IR). Our team provides rapid-response technical support to clarify data points and supports post-marketing regulatory maintenance to ensure the long-term viability of the product.

Applications

• Next-Generation Incretin Mimetics: We offer comprehensive regulatory support for complex peptide-based therapies, including GLP-1, GIP, and glucagon receptor multi-agonists. Our services specifically address the intricate safety profiles and dose-titration strategies required for these dual and triple agonists to satisfy global pharmacovigilance standards.
• Novel Small Molecule Metabolic Agents: Expert regulatory guidance for the development of oral, non-peptide therapies targeting weight loss. We assist sponsors in navigating the unique bioavailability, gastrointestinal tolerability, and PK/PD modeling requirements that health authorities prioritize for these innovative delivery formats.
• Strategic Comorbidity Labeling: Securing regulatory approval for expanded claims and secondary indications is critical for market differentiation. We provide the scientific and technical support necessary to integrate data from cardiovascular outcome trials (CVOT) and metabolic studies into labels for NASH/MASH, chronic kidney disease (CKD), and obstructive sleep apnea.

Advantages

Connect Us to Conduct a Regulatory Risk Assessment and Streamline Your Global Filing Strategy.

Customer Review

Frequently Asked Questions

1. Do you handle the technical complexities of the electronic submission (eCTD) process?

   Yes, Protheragen manages the end-to-end technical validation and secure transmission of eCTD submissions. We ensure that your dossiers meet the rigid formatting and hyperlinking requirements of all major health authorities, reducing the risk of technical rejections and ensuring a seamless transition from preparation to formal agency review.

2. Can Protheragen help us secure Expedited Programs like Breakthrough Therapy Designation?

   Yes, we evaluate your clinical data against agency criteria for breakthrough therapy, fast track, or priority review. Our team authors the formal request packages, emphasizing the clinical significance of your weight-loss data to justify accelerated regulatory pathways.

3. What is your approach to responding to complex CMC IR from agencies?

   We don't just facilitate the response; we provide the scientific expertise to resolve the query. Our CMC consultants work with your lab teams to generate the necessary data and draft responses that directly address the agency's underlying technical concerns.

Protheragen provides the scientific depth and regulatory precision necessary to navigate the complex path to market for obesity therapies. From initial gap analysis to successful health authority inspections, we are committed to your project's success. We warmly welcome you to contact us at any time to explore how we build the most robust regulatory pathway for your innovative therapies.